3 engraftment on bone marrow aspirate. Clinical case reports suggest that human autoimmune Her post-transplant course was largely uncomplicated disease may be similarly transferred. Insulin-dependent with the exception of slow recovery of blood counts. diabetes mellitus, 4 autoimmune thyroiditis, 5 autoimmune Although she developed erythema over her shoulders and poly-endocrine failure, 6 immune thrombocytopenia 7 and culture-negative diarrhoea these symptoms resolved sponpsoriasis 8, 9 have developed in recipients of BMT from taneously and there was no definite evidence of graftdonors with a history of those diseases. The onset of autoversus-host disease. Cyclosporine was tapered and stopped immunity has usually been distantly related to the time of at 1 year post-BMT. After the transplant, bone marrow transplant, in some cases by several years. cytogenetics were consistently negative for the Philadelphia Such cases have given rise to concern that transfer of chromosome, although RT-PCR amplification of the bcr/abl autoimmune disease might complicate blood and bone martranslocation confirmed a low level of residual leukaemia row stem cell transplantation. We describe the long-term transiently from 17 to 24 months post-BMT after which it follow-up of a patient who received allogeneic bone marbecame negative again. At the time of writing in December 1996, the patient continues to be in remission.
Prior to transplant the patient had no evidence of arthro- although the antinuclear antibody (ANA) titre was raised at 1:160 in a homogeneous pattern. Since 1994, the patient transfer of other autoimmune conditions. The reason why this occurs in some cases and not others is not clear. The has developed osteoarthritis in her distal interphalangeal joints, both knees and neck, but no clinical evidence of RA.
nature of the disease may be an important factor. The cellular immune disorder of rheumatoid arthritis and SLE is Rheumatoid factor is negative although the ANA remains mildly elevated. Erythrocyte sedimentation rate (ESR) and complex, with multicellular dysfunction of T and B lymphocytes, monocytes, macrophages, antigen presenting C-reactive protein are normal. The patient's sister continues to have active rheumatoid arthritis reflected by an ESR of cells and other cells. The role that T cells play in these conditions is relatively poorly defined, and paradoxically, 80 mm/h and progressive disability.
We used PCR amplification of YNZ22, a highly polyis characterised by inactivity. 12,13 It could be mooted that fundamental pathophysiological differences account for the morphic VNTR locus on chromosome 17, to investigate haemopoietic and immune reconstitution of peripheral apparent transfer by BMT of organ-specific diseases such as ITP, psoriasis, thyroiditis, and type I diabetes mellitus. blood. 10 Briefly, after red cell lysis, PCR was performed on 200 ng of phenol extracted peripheral blood leukocyte An alternative explanation as to why RA was not transferred to our patient is that post-transplant cyclosporine and DNA using 5′ and 3′ primers to YNZ22 and Taq polymerase. Thermal cycling was performed at 95°C for 1 min, methotrexate may have inhibited the development of RA, although graft-versus-host disease prophylaxis/treatment then 95°C for 20 s, 50.5°C for 20 s, 72°C for 30 s for 34 cycles then 72°C for 5 min and held at 4°C. Amplified was also used in most of the cases where organ-specific autoimmune disease was apparently transferred. products were examined by polyacrylamide gel electrophoresis, stained with ethidium bromide and bands visual-
The potential for high-dose therapy and autologous stem cell transplantation as a treatment for established severe ised with ultraviolet light. Using dilutional series, we found this method to have a lower limit of sensitivity of 1.6%.
autoimmune disease is currently being investigated. 14 The issue of manipulation of the peripheral blood stem and proResults, shown in Figure 1 , confirm complete haemopoietic and immune reconstitution of recipient blood by that of the genitor cells harvests to remove cells (at least in theory and based on animal data) capable of reactivating the autodonor with no evidence of mixed chimerism.
immune process warrants investigation. However, such depletion may be unnecessary if, as suggested by our case and that of Sturfelt et al, T lymphocytes or other cells Discussion present in the harvest are incapable of initiating the complex cellular interplay necessary to activate the autoimmune The above case is similar to that recently reported by Sturfelt et al 11 in that adoptive transfer of human autoimmunity process. Randomised clinical trials may therefore be justified in this area. does not necessarily occur despite complete immune reconstitution by the haematopoietic system from a patient with systemic autoimmune disease. These observations are of References clinical importance in that they reassure that systemic autoimmune disease in a potential donor should not necessarily 1 Marmont AM. Immune ablation followed by allogeneic or be a deterrent for allogeneic blood or bone marrow trans- 
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